Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is
more common in Asia, its incidence in Europe and North America has significantly increased …

Cholangiocarcinoma, the second most common hepatobiliary malignancy after
hepatocellular carcinoma, is a heterogeneous disease entity with widely varying radiologic …

This paper presents the first version of clinical practice guidelines for intrahepatic
cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These …

Background & Aims The role of 18 F-fluorodeoxyglucose positron emission tomography (18
FDG-PET) in the diagnosis and staging of patients with biliary tract cancers (BTCs) remains …

Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection,
though this treatment is possible in less than 40% of patients. However, recent …

Lymph node (LN) metastasis from intrahepatic cholangiocarcinoma (IHCC) might be one of
the most important indicators of aggressive surgical resection, yet the value of LN dissection …

Purpose Although intrahepatic cholangiocarcinoma (ICC) is the second most common
primary hepatic malignancy after hepatocellular carcinoma, there are limited data available …

To this date, it is a major oncological challenge to optimally diagnose, stage, and manage
intrahepatic cholangiocarcinoma (ICC). Imaging can not only diagnose and stage ICC, but it …

Simple Summary Contrast imaging techniques play a pivotal role in the diagnosis and
management of Intrahepatic cholangiocarcinoma (iCCA). There is an increasing interest in …

Abstract Objectives Role of 18-FDG PET/CT had been well established in other more
prevalent malignancies such as colorectal and lung cancer; however, this is not as well …